Stock Market Alerts: Special Alert and Coverage Issued for RBRM! September 19, 2007

Market Wire, September, 2007

Stock Market Alerts' performance stock list includes: ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM), Generex Biotechnology Corp. (NASDAQ: GNBT), Medtronic, Inc. (NYSE: MDT), Novavax, Inc. (NASDAQ: NVAX).

Having just announced yesterday morning it has reached $1.5 million in sales, ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM) should have investors monitoring the stock closely as the company made its second announcement for Tuesday. The company, an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D, issued a press release Tuesday after the markets closed announcing the appointment of Foot-O-Pedics to be the exclusive distributor of its ReBuilder System for diabetic Peripheral Neuropathy in Maine.

Great news for RBRM investors! David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc. said, "We are pleased to add Foot-O-Pedics to our growing line of distributors and exclusively in Maine. They have a fantastic reputation and we have found that local representation and a personal demonstration lends credibility to our older customers who suffer from pain and tingling in their feet."

Foot-O-Pedics is a family-owned and operated business that prides itself in providing quality products and customer service. "We will commit to advertising the products in newspapers, TV and possibly radio," says Larry Gowell, President of Foot-O-Pedics. "We will also use direct mail to invite residents of Maine into our offices for a free demonstration of the ReBuilder."

In yesterday morning's press release, Daena Carter, Director of Accounting of ReBuilder Medical Technologies, Inc., stated, "It took us almost 4 years to reach $1 million in sales, and in 2007 alone, we have crossed the $1.5 million mark. These figures exceeded our 2006 target by 15% due to the infusion of international sales. Sales from foreign countries have increased by 15% in 2007. As a result we are actively seeking distributors and international representation for our products. The International Diabetes Federation estimates that over 230 million people worldwide now live with diabetes. Neuropathy is known to affect more than 30% of all diabetes sufferers."

ReBuilder Medical Technologies is certainly another company to watch closely! Last week, Rebuilder Medical Technologies reported to its board of directors that it has expanded its international customer base to include England, Canada, New Zealand and Australia. In a separate press release, the company also announced a marketing agreement with Affiliated Services, Inc. of Tampa, Florida. The marketing agreement enables Affiliated Services to market ReBuilder's products to the entire market of 155,000 physical therapists across the U.S..

Before the news was released, the stock closed Tuesday at Eighty Seven cents a share.

For Stock Market Alerts' in-depth profile of ReBuilder Medical Technologies, visit http://www.wallstreetenews.com/HotStocks/RBRM091807/default.aspx

The company is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship product is its FDA registered ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located in Charles Town, WV. He is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System for the early detection of breast cancer and the AcuPen which detects acupuncture points and then treats them.

Other Stocks of interest yesterday were:

Generex Biotechnology Corporation (NASDAQ: GNBT) even on 345,000 shares traded. Generex is engaged in the research and development of drug delivery systems and technologies.

Medtronic, Inc., (NYSE: MDT) up 2.1% on 9.7 million shares traded. Medtronic, Inc. is one of the leaders in medical technology.

Novavax, Inc. (NASDAQ: NVAX) up 1.1% on 224,000 shares traded. Novavax is focused on creating differentiated, value-added pharmaceutical and vaccine products and technologies.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for ReBuilder Medical Technologies, Inc. (PINKSHEETS: RBRM). The compensation is twenty four thousand dollars from third party, CLX & Associates, who is non-affiliated and may hold a significant position in the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.